Cutter & CO Brokerage, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,025 filers reported holding NOVARTIS A G in Q3 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cutter & CO Brokerage, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2022$940,000
-6.3%
11,124
-2.7%
0.32%
+7.7%
Q1 2022$1,003,000
-2.0%
11,429
-2.3%
0.30%
+6.4%
Q4 2021$1,023,000
+30.3%
11,694
+21.8%
0.28%
+49.7%
Q3 2021$785,000
-2.6%
9,604
+8.8%
0.19%
+1.1%
Q2 2021$806,000
+7.2%
8,829
+0.4%
0.18%
+0.5%
Q1 2021$752,000
-8.8%
8,794
+0.6%
0.18%
-15.2%
Q4 2020$825,000
+4.2%
8,741
-4.0%
0.22%
-7.7%
Q3 2020$792,000
-7.7%
9,106
-7.3%
0.24%
-15.8%
Q2 2020$858,000
+4.4%
9,826
-1.5%
0.28%
-10.0%
Q1 2020$822,000
-16.5%
9,975
-4.1%
0.31%
-10.4%
Q4 2019$985,000
+9.0%
10,3970.0%0.35%
+18.9%
Q3 2019$904,000
-8.3%
10,397
-3.7%
0.29%
-6.4%
Q2 2019$986,000
-15.8%
10,797
-11.4%
0.31%
-6.6%
Q1 2019$1,171,000
+11.4%
12,183
-0.5%
0.33%
-16.5%
Q4 2018$1,051,000
+1.4%
12,247
+1.8%
0.40%
+12.7%
Q3 2018$1,037,000
+19.2%
12,036
+4.5%
0.35%
+5.7%
Q2 2018$870,000
-7.5%
11,519
-1.1%
0.34%
-9.9%
Q1 2018$941,000
-4.2%
11,642
-0.5%
0.37%
-7.9%
Q4 2017$982,000
+2.6%
11,697
+4.9%
0.40%
+6.6%
Q3 2017$957,000
-0.7%
11,147
-3.5%
0.38%0.0%
Q2 2017$964,000
+9.9%
11,547
-2.2%
0.38%
+4.7%
Q1 2017$877,000
-0.9%
11,811
-2.8%
0.36%
-1.1%
Q4 2016$885,000
-2.7%
12,146
+5.4%
0.37%
-7.8%
Q3 2016$910,000
-6.1%
11,521
-1.9%
0.40%
-4.1%
Q2 2016$969,000
+18.6%
11,748
+4.2%
0.41%
+9.5%
Q1 2016$817,00011,2760.38%
Other shareholders
NOVARTIS A G shareholders Q3 2018
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders